Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_1
2
50%
Ph phase_3
1
25%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Other(1)

Detailed Status

Not yet recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 12 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

active_not_recruiting125%
not_yet_recruiting250%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingphase_3

Bacteriophage Therapy for Orthopedic Implant-Associated Infections

NCT07533292
not_yet_recruitingphase_1

Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis

NCT06750588
active_not_recruitingphase_1

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease

NCT03808103
unknownnot_applicable

Experimental Phage Therapy of Bacterial Infections

NCT00945087

Clinical Trials (4)

Showing 4 of 4 trials
NCT07533292Phase 3

Bacteriophage Therapy for Orthopedic Implant-Associated Infections

Not Yet Recruiting
NCT06750588Phase 1

Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis

Not Yet Recruiting
NCT03808103Phase 1

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease

Active Not Recruiting
NCT00945087Not Applicable

Experimental Phage Therapy of Bacterial Infections

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4